Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

33482625641_c7347cbaba_h

AI and neurology: How machine learning is revolutionising neuroscience

Manufacturing and Production |

 

Feature

Medical cannabis: The next innovation in oncology?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

The market for medical cannabis has been growing steadily over the last decade, but it may be on the cusp …

Feature
drugcosts-edt-jumbo

Pharma disputes, fines, and the work of the CMA

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

Several pharmaceutical firms have lately been fined for unfairly hiking prices over the years, meaning that patients and the NHS …

Feature
pers

Personalised medicine in oncology: Where are we now?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …

Feature
close-up-of-female-hands-holding-medication-bottle-royalty-free-image-1612294037

Exploring the potential of drug repurposing

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | drug repurposing

Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …

Feature

Biosimilars and Brexit: What’s in store for UK’s biosimilar market?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biosimilars, brexit

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …

Feature

The importance of representation in clinical trials

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Representation, clinical trials

Before any kind of new medicine can be made available to the market, it has to go through a strictly …

Feature

Are we on the cusp of an AI revolution?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …

Feature

Navigating through the post-COVID-19 R&D bottleneck

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

Jack Goddard inve

Feature
1558469633615

The Truth Behind the £1.8 Million Drug

Manufacturing and Production | FDA, NHS, NICE

As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug …

Feature
hsm_mobile_clinical_trial_istock-872676342

Real-world evidence and clinical research diversity

Research and Development | rwe

Clinical trials are immensely valuable in establishing the safety and effectiveness of a drug in carefully selected participants, but what …

Feature
cov

MAPs during a global pandemic

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, MAPS

Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …

Feature

How COVID-19 has changed pharmacovigilance

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, pharmacovigilance

The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …

Feature
drug-trials

How COVID-19 has affected the oncology drugs market

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | COVID-19, Cancer

In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …

Feature

The importance of ethics and patient centricity in managed and early access programmes

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025